会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Cryotreatment pellet
    • 冷冻沉淀
    • US08747397B2
    • 2014-06-10
    • US13683140
    • 2012-11-21
    • CPSI Holdings LLC
    • John M. BaustJohn G. BaustAnthony T. RobilottoKristi K. SnyderRobert G. Van Buskirk
    • A61B18/02
    • A61B18/02A61B2018/0212A61K9/0024A61K9/145A61K31/00A61K31/282A61K31/337A61K31/513A61K31/59A61K31/7048A61K45/06A61M5/44A61M37/0069A61M2205/3606
    • The resorbable cryoprobe device and process is a novel approach for treating localized disease allowing for the precise combined application of freezing temperatures and cytotoxic or cryosensitizing agents within a self-contained matrix/package for optimized tissue destruction. The cryopellet is comprised of a list of components including a source of cryogen to produce the sub-zero temperatures, a porous matrix to contain the cytotoxic agent, cytotoxic agent, and a delivery packet. Data presented herein demonstrates the efficacy of this approach in destroying cancerous tissue. For example, the application of freezing temperatures to −10° C. results in approximately 15% cell death, while exposure to cytotoxic agents such as TRAIL produces minimal cell death. The utilization of the cryopellet approach results in a synergistic effect yielding complete cell death at the same temperature. The innovation behind the resorbable probe application includes the strategic combination of agents to activate intrinsic or extrinsic cell death responses (including apoptosis and necrosis), unique packaging of the cryogen and cytotoxic agent, and a unique delivery system. The resorbable cryoprobe technology will assist directly in the treatment of cancer, as well as will likely lead to broader application for disease treatment.
    • 可再吸收的冷冻探针装置和方法是用于治疗局部疾病的新方法,其允许在自包含的基质/包装内精确地联合应用冷冻温度和细胞毒性或冷冻敏化剂以优化组织破坏。 冷冻条由包括产生低于零温度的冷冻源的组分的列表组成,含有细胞毒剂,细胞毒性剂和递送包的多孔基质。 本文提供的数据显示了这种方法在破坏癌组织中的功效。 例如,将冻结温度施加到-10℃导致约15%的细胞死亡,而暴露于细胞毒性剂如TRAIL的细胞会导致最小的细胞死亡。 cryopellet方法的利用导致在相同温度下产生完全细胞死亡的协同效应。 可再吸收探针应用的创新包括激活内在或外在细胞死亡反应(包括细胞凋亡和坏死),冷冻剂和细胞毒性剂的独特包装以及独特的递送系统的药剂的战略组合。 可再吸收的冷冻探针技术将有助于直接治疗癌症,并可能导致更广泛的疾病治疗应用。
    • 4. 发明申请
    • CRYO-MEDICAL INJECTION DEVICE AND METHOD OF USE
    • CRYO医疗注射装置及其使用方法
    • US20130079761A1
    • 2013-03-28
    • US13683140
    • 2012-11-21
    • CPSI HOLDINGS LLC
    • John M. BaustJohn G. BaustAnthony T. RobilottoKristi K. SnyderRobert G. Van Buskirk
    • A61B18/02
    • A61B18/02A61B2018/0212A61K9/0024A61K9/145A61K31/00A61K31/282A61K31/337A61K31/513A61K31/59A61K31/7048A61K45/06A61M5/44A61M37/0069A61M2205/3606
    • The resorbable cryoprobe device and process is a novel approach for treating localized disease allowing for the precise combined application of freezing temperatures and cytotoxic or cryosensitizing agents within a self-contained matrix/package for optimized tissue destruction. The cryopellet is comprised of a list of components including a source of cryogen to produce the sub-zero temperatures, a porous matrix to contain the cytotoxic agent, cytotoxic agent, and a delivery packet. Data presented herein demonstrates the efficacy of this approach in destroying cancerous tissue. For example, the application of freezing temperatures to −10° C. results in approximately 15% cell death, while exposure to cytotoxic agents such as TRAIL produces minimal cell death. The utilization of the cryopellet approach results in a synergistic effect yielding complete cell death at the same temperature. The innovation behind the resorbable probe application includes the strategic combination of agents to activate intrinsic or extrinsic cell death responses (including apoptosis and necrosis), unique packaging of the cryogen and cytotoxic agent, and a unique delivery system. The resorbable cryoprobe technology will assist directly in the treatment of cancer, as well as will likely lead to broader application for disease treatment.
    • 可再吸收的冷冻探针装置和方法是用于治疗局部疾病的新方法,其允许在自包含的基质/包装内精确地联合应用冷冻温度和细胞毒性或冷冻敏化剂以优化组织破坏。 冷冻条由包括产生低于零温度的冷冻源的组分的列表组成,含有细胞毒剂,细胞毒性剂和递送包的多孔基质。 本文提供的数据显示了这种方法在破坏癌组织中的功效。 例如,将冻结温度施加到-10℃导致约15%的细胞死亡,而暴露于细胞毒性剂如TRAIL的细胞会导致最小的细胞死亡。 cryopellet方法的利用导致在相同温度下产生完全细胞死亡的协同效应。 可再吸收探针应用的创新包括激活内在或外在细胞死亡反应(包括细胞凋亡和坏死),冷冻剂和细胞毒性剂的独特包装以及独特的递送系统的药剂的战略组合。 可再吸收的冷冻探针技术将有助于直接治疗癌症,并可能导致更广泛的疾病治疗应用。